DEFINING THE ROLE OF ANTI-NEPHRIN ANTIBODIES IN THE RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS POST TRANSPLANTATION

$1,618,114FY2025Defense Health AgencyDOD

The General Hospital Corporation

Investigators